A myriad of pathways to NASH

S Larrain, ME Rinella - Clinics in liver disease, 2012 - Elsevier
Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of
macrovesicular steatosis, cellular ballooning, and inflammation. NASH represents a …

A myriad of pathways to NASH.

S Larrain, ME Rinella - Clinics in Liver Disease, 2012 - europepmc.org
Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of
macrovesicular steatosis, cellular ballooning, and inflammation. NASH represents a …

A Myriad of Pathways to NASH

S Larrain, ME Rinella - Clinics in Liver Disease, 2012 - liver.theclinics.com
Nonalcoholic steatohepatitis (NASH), the progressive phenotype of nonalcoholic fatty liver
disease (NAFLD), represents the end product of a myriad of pathogenic mechanisms with …

A myriad of pathways to NASH

S Larrain, ME Rinella - Clinics in liver disease, 2012 - pubmed.ncbi.nlm.nih.gov
Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of
macrovesicular steatosis, cellular ballooning, and inflammation. NASH represents a …

A Myriad of Pathways to NASH

S Larrain, ME Rinella - … Fatty Liver Disease, An Issue of Clinics in …, 2012 - books.google.com
Endocrine disorders, such as growth hormone deficiency and hypothyroidism, should be
considered when evaluating patients with NASH. Several genetic, metabolic and nutritional …

A Myriad of Pathways to NASH

S Larrain, ME Rinella - Clinics in liver disease, 2012 - scholars.northwestern.edu
Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of
macrovesicular steatosis, cellular ballooning, and inflammation. NASH represents a …

A Myriad of Pathways to NASH

S Larrain, ME Rinella - Clinics in Liver Disease, 2012 - hero.epa.gov
Nonalcoholic steatohepatitis (NASH) is defined histopathologically by the presence of
macrovesicular steatosis, cellular ballooning, and inflammation. NASH represents a …